Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Raghavendra Rao & R Vijayalakshmi Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Raghavendra Rao Standalone Financial Results, Limited Review Report, Results Press Release for September 30, 2016
Orchid Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 20163. Result Press Release for the period ended September 30, 2016 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Board Meeting Intimation for Results & Closure of Trading Window
Orchid Pharma Ltd has informed BSE that a meeting of the Board of Directors is proposed to be held on November 09, 2016, to approve the unaudited financial results of the Company for the period from July 01, 2016 to September 30, 2016.As required under the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company shall remain closed for all the insiders from October 29, 2016 to November 11, 2016 (both days inclusive). Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghvendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Orchid Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended September 30, 2016
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Orchid Pharma Ltd has informed BSE regarding the details of Voting results at the 23rd Annual General Meeting (AGM) of the Company held on September 28, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.